XML 20 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
IPO
Convertible Preferred Stock
Common Stock
Common Stock
IPO
Additional Paid-in Capital
Additional Paid-in Capital
IPO
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2020 $ (421,184)     $ 2   $ 8,216   $ 30 $ (429,432)
Beginning balance (in shares) at Dec. 31, 2020     134,113            
Beginning balance at Dec. 31, 2020     $ 852,897            
Beginning balance (in shares) at Dec. 31, 2020       16,170          
Conversion of convertible preferred stock into common stock upon initial public offering 852,897     $ 13   852,884      
Conversion of convertible preferred stock into common stock, upon initial public offering (in shares)     (134,113)            
Conversion of convertible preferred stock into common stock, upon initial public offering     $ (852,897)            
Conversion of convertible preferred stock into common stock, upon initial public offering (in shares)       134,113          
Issuance of common stock in initial public offering, net of offering costs   $ 626,405     $ 3   $ 626,402    
Issuance of common stock in initial public offering, net of offering costs (in shares)         27,025        
Vesting of restricted stock (in shares)       1,428          
Exercise of stock options 298         298      
Exercise of stock options (in shares)       205          
Stock-based compensation expense 4,158         4,158      
Unrealized loss on marketable securities, net 26             26  
Net income (loss) (180,617)               (180,617)
Ending balance at Mar. 31, 2021 881,983     $ 18   1,491,958   56 (610,049)
Ending balance (in shares) at Mar. 31, 2021       178,941          
Beginning balance at Dec. 31, 2020 (421,184)     $ 2   8,216   30 (429,432)
Beginning balance (in shares) at Dec. 31, 2020     134,113            
Beginning balance at Dec. 31, 2020     $ 852,897            
Beginning balance (in shares) at Dec. 31, 2020       16,170          
Net income (loss) (161,934)                
Ending balance at Jun. 30, 2021 905,897     $ 18   1,497,232   13 (591,366)
Ending balance (in shares) at Jun. 30, 2021       180,576          
Beginning balance at Mar. 31, 2021 881,983     $ 18   1,491,958   56 (610,049)
Beginning balance (in shares) at Mar. 31, 2021       178,941          
Vesting of restricted stock (in shares)       1,423          
Exercise of stock options 333         333      
Exercise of stock options (in shares)       212          
Stock-based compensation expense 4,941         4,941      
Unrealized loss on marketable securities, net (43)             (43)  
Net income (loss) 18,683               18,683
Ending balance at Jun. 30, 2021 905,897     $ 18   1,497,232   13 (591,366)
Ending balance (in shares) at Jun. 30, 2021       180,576          
Beginning balance at Dec. 31, 2021 $ 728,502     $ 18   1,515,210   (1,366) (785,360)
Beginning balance (in shares) at Dec. 31, 2021 184,929     184,929          
Vesting of restricted stock       $ 1   (1)      
Vesting of restricted stock (in shares)       1,419          
Exercise of stock options $ 652         652      
Exercise of stock options (in shares)       284          
Stock-based compensation expense 7,755         7,755      
Unrealized loss on marketable securities, net (3,806)             (3,806)  
Net income (loss) (31,448)               (31,448)
Ending balance at Mar. 31, 2022 701,655     $ 19   1,523,616   (5,172) (816,808)
Ending balance (in shares) at Mar. 31, 2022       186,632          
Beginning balance at Dec. 31, 2021 $ 728,502     $ 18   1,515,210   (1,366) (785,360)
Beginning balance (in shares) at Dec. 31, 2021 184,929     184,929          
Exercise of stock options (in shares) 604                
Net income (loss) $ (103,913)                
Ending balance at Jun. 30, 2022 $ 639,505     $ 19   1,535,106   (6,347) (889,273)
Ending balance (in shares) at Jun. 30, 2022 188,430     188,430          
Beginning balance at Mar. 31, 2022 $ 701,655     $ 19   1,523,616   (5,172) (816,808)
Beginning balance (in shares) at Mar. 31, 2022       186,632          
Vesting of restricted stock (in shares)       1,243          
Exercise of stock options 571         571      
Exercise of stock options (in shares)       320          
Issuance of common stock related to employee stock purchase plan 1,008         1,008      
Issuance of common stock related to employee stock purchase plan, Shares       235          
Stock-based compensation expense 9,911         9,911      
Unrealized loss on marketable securities, net (1,175)             (1,175)  
Net income (loss) (72,465)               (72,465)
Ending balance at Jun. 30, 2022 $ 639,505     $ 19   $ 1,535,106   $ (6,347) $ (889,273)
Ending balance (in shares) at Jun. 30, 2022 188,430     188,430